| Nervous system involvement after infection with COVID-19 and other coronaviruses Y Wu, X Xu, Z Chen, J Duan, K Hashimoto, L Yang, C Liu, C Yang Brain, behavior, and immunity 87, 18-22, 2020 | 2591 | 2020 |
| Vicarious traumatization in the general public, members, and non-members of medical teams aiding in COVID-19 control Z Li, J Ge, M Yang, J Feng, M Qiao, R Jiang, J Bi, G Zhan, X Xu, L Wang, ... Brain, behavior, and immunity 88, 916-919, 2020 | 1573 | 2020 |
| Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants E Shimizu, K Hashimoto, N Okamura, K Koike, N Komatsu, C Kumakiri, ... Biological psychiatry 54 (1), 70-75, 2003 | 1560 | 2003 |
| Increased levels of glutamate in brains from patients with mood disorders K Hashimoto, A Sawa, M Iyo Biological psychiatry 62 (11), 1310-1316, 2007 | 756 | 2007 |
| Critical role of brain-derived neurotrophic factor in mood disorders K Hashimoto, E Shimizu, M Iyo Brain research reviews 45 (2), 104-114, 2004 | 731 | 2004 |
| R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects C Yang, Y Shirayama, JC Zhang, Q Ren, W Yao, M Ma, C Dong, ... Translational psychiatry 5 (9), e632-e632, 2015 | 610 | 2015 |
| Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia K Hashimoto, T Fukushima, E Shimizu, N Komatsu, H Watanabe, ... Archives of general psychiatry 60 (6), 572-576, 2003 | 605 | 2003 |
| Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia K Ozawa, K Hashimoto, T Kishimoto, E Shimizu, H Ishikura, M Iyo Biological psychiatry 59 (6), 546-554, 2006 | 574 | 2006 |
| Brain-derived neurotrophic factor (BDNF)-TrkB signaling in inflammation-related depression and potential therapeutic targets J Zhang, W Yao, K Hashimoto Current neuropharmacology 14 (7), 721-731, 2016 | 522 | 2016 |
| Brain‐derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions K Hashimoto Psychiatry and clinical neurosciences 64 (4), 341-357, 2010 | 515 | 2010 |
| Effect of multimodal microstructure evolution on mechanical properties of Mg–Zn–Y extruded alloy M Yamasaki, K Hashimoto, K Hagihara, Y Kawamura Acta Materialia 59 (9), 3646-3658, 2011 | 502 | 2011 |
| Emerging role of glutamate in the pathophysiology of major depressive disorder K Hashimoto Brain research reviews 61 (2), 105-123, 2009 | 485 | 2009 |
| Knowledge and attitudes of medical staff in Chinese psychiatric hospitals regarding COVID-19 Y Shi, J Wang, Y Yang, Z Wang, G Wang, K Hashimoto, K Zhang, H Liu Brain, behavior, & immunity-health 4, 100064, 2020 | 447 | 2020 |
| Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: the possibility to explain ethnic mental traits. E Shimizu, K Hashimoto, M Iyo Wiley-Blackwell Publishing Ltd., 2004 | 402 | 2004 |
| R (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine J Zhang, S Li, K Hashimoto Pharmacology Biochemistry and Behavior 116, 137-141, 2014 | 400 | 2014 |
| Current status of potential therapeutic candidates for the COVID-19 crisis J Zhang, B Xie, K Hashimoto Brain, behavior, and immunity 87, 59-73, 2020 | 388 | 2020 |
| Interactions of selective serotonin reuptake inhibitors with subtypes of σ receptors in rat brain N Narita, K Hashimoto, S Tomitaka, Y Minabe European journal of pharmacology 307 (1), 117-119, 1996 | 353 | 1996 |
| Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective K Hashimoto Psychiatry and clinical neurosciences 73 (10), 613-627, 2019 | 343 | 2019 |
| Calcium decoding mechanisms in plants K Hashimoto, J Kudla Biochimie 93 (12), 2054-2059, 2011 | 322 | 2011 |
| Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients K Hashimoto, G Engberg, E Shimizu, C Nordin, LH Lindström, M Iyo Progress in Neuro-Psychopharmacology and Biological Psychiatry 29 (5), 767-769, 2005 | 316 | 2005 |
Yukihiko ShirayamaTeikyo University Chiba Medical CenterПотвърден имейл адрес: rapid.ocn.ne.jp